GDS — Ramsay Generale De Sante SA Income Statement
0.000.00%
- €993.21m
- €4.73bn
- €5.24bn
Annual income statement for Ramsay Generale De Sante SA, fiscal year end - June 30th, EUR millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,023 | 4,301 | 4,702 | 5,007 | 5,242 |
Cost of Revenue | |||||
Gross Profit | 3,204 | 3,410 | 3,723 | 3,943 | 4,084 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,772 | 4,010 | 4,461 | 4,846 | 5,069 |
Operating Profit | 251 | 291 | 240 | 161 | 173 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 103 | 184 | 87.7 | -40.8 | -36.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.8 | 127 | 63.9 | -36.7 | -38.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 65 | 118 | 49.4 | -53.9 | -54.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 65 | 118 | 49.4 | -53.9 | -54.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.58 | -0.229 | -0.402 | -0.704 | -0.388 |
Dividends per Share |